Taikang increases its stake in Fosun Pharma; insurance capital accelerates investment in innovative drugs.
```
On November 26, Taikang Life Insurance issued a shareholder disclosure announcement, revealing that the company’s Hong Kong subsidiary has increased its holdings in Fosun Pharma’s H shares by 518,500 shares, raising its stake to 5.1% of the company’s H share capital.
Prior to this move,